Some tumors, such as glioblastomas, express only standard CD44, while others, including gastrointestinal cancers, bladder cancer, cervical cancer, breast cancer, and non-Hodgkin lymphoma, also express CD44 variants (122). Here, CD44 is linked to non-Hodgkin lymphoma.